Skip to main content
. 2022 Nov 11;14(1):2139979. doi: 10.1080/19490976.2022.2139979

Table 1.

Demographics.

  CRC (12) AA (10) Polyps (11) Control (20)
Age (median [IQR]) 67 [60–71] 71 [70–73] 73 [60–75] 67 [62–75]
Gender (male No [%]) 6 [50] 9 [90.0] 9 [81.2] 14 [70]
BMI (median [IQR]) 25.1 [23.7–31.1] 26.9 [23.5–28.4] 26.8 [23.7–29.1] 25.5 [22.9 − 28.7]
Smoking status (No[%])        
Never smoked 2 [16.7] 1 [10] 3 [27.3] 6 [13]
Stopped smoking 9 [75.0] 8 [80] 6 [44.6] 12 [60]
Actively smoking 1 [8.33] 1 [10] 2 [18.2] 2 [10]
Endoscopy indication (No [%])        
Positive FIT 6 [50] 3 [13] 3 [27.3] 3 [14]
Rectal blood loss 4 [33.3] 4 [15] 0 [0] 1 [5.0]
Abdominal pain 1 [8.33] 1 [10] 1 [9.1] 6 [13]
Diarrhea 0 [0] 0 [0] 1 [9.1] 0 [0]
Change in bowel habits 1 [8.33] 1 [10] 1 [9.1] 3 [14]
Polyp surveillance 0 [0] 1 [10] 2 [18.2] 2 [10]
Surveillance on family history 0 [0] 1 [10] 0 [0] 1 [5.0]
Incontinence 0 [0] 0 [0] 1 [9.1] 0 [0]
Coincidental radiologic finding 0 [0] 0 [0] 0 [0] 0 [0]
Surveillance after CRC 0 [0] 0 [0] 2 [18.2] 1 [5.0]
Anemia 1 [8.33] 0 [0] 0 [0] 1 [5.0]
Localization largest abnormality (No [%])*        
Cecum 0 [0] 1 [10] 2 [18.2] NA
Ascending colon 1 [8.33] 1 [10] 3 [27.3] NA
Flexura Hepatica 1 [8.33] 0 [0] 0 [0] NA
Transversal colon 0 [0] 0 [0] 1 [9.1] NA
Flexura lienalis 0 [0] 1 [10] 0 [0] NA
Descending colon 0 [0] 0 [0] 0 [0] NA
Sigmoid 6 [50] 4 [15] 4 [36.4] NA
Rectosigmoid 2 [16.7] 0 [0] 0 [0] NA
Rectum 1 [8.33] 2 [16] 1 [9.1] NA
AA Characteristics (No [%])        
High grade dysplasia NA 0 [0] NA NA
Villous histology NA 4 [15] NA NA
>1 cm NA 9 [90] NA NA
Polyp characteristics (No [%])        
No dysplasia NA NA 0 [0] NA
Hyperplastic NA NA 0 [0] NA
Low grade dysplasia NA NA 11 [100] NA
Number of adenomas removed (median [IQR]) 2 [1–4] 3 [2–4] 2 [1–3] NA

Demographics of study participants. Abbreviations: CRC = colorectal cancer, AA = advanced adenoma, IQR = interquartile range, NA = not applicable. In this study, AA and polyps were combined into one adenoma group. All CRC were adenocarcinomas *Information on localization of lesion missing for one participants of the CRC and AA group.